MCL coexpression mm9:619
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr14:71018347..71018381,- | p5@Epb4.9 |
Mm9::chr17:28145497..28145525,- | p1@ENSMUST00000156965 |
Mm9::chr6:17257254..17257270,+ | p9@Cav1 |
Mm9::chr6:17257272..17257287,+ | p10@Cav1 |
Mm9::chr6:17257659..17257744,+ | p1@Cav1 |
Mm9::chr6:17257746..17257750,+ | p14@Cav1 |
Mm9::chr6:17257878..17257893,+ | p7@Cav1 |
Mm9::chr6:17257899..17257921,+ | p4@Cav1 |
Mm9::chr6:17257943..17257959,+ | p8@Cav1 |
Mm9::chr6:17289478..17289493,+ | p@chr6:17289478..17289493 + |
Mm9::chr7:16535631..16535670,- | p@chr7:16535631..16535670 - |
Mm9::chrX:96085769..96085827,- | p2@Ophn1 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0033483 | gas homeostasis | 0.006299989005677 |
GO:0052547 | regulation of peptidase activity | 0.006299989005677 |
GO:0030857 | negative regulation of epithelial cell differentiation | 0.006299989005677 |
GO:0045908 | negative regulation of vasodilation | 0.006299989005677 |
GO:0033484 | nitric oxide homeostasis | 0.006299989005677 |
GO:0042312 | regulation of vasodilation | 0.006299989005677 |
GO:0030036 | actin cytoskeleton organization and biogenesis | 0.006299989005677 |
GO:0030029 | actin filament-based process | 0.006299989005677 |
GO:0045907 | positive regulation of vasoconstriction | 0.006299989005677 |
GO:0048552 | regulation of metalloenzyme activity | 0.006299989005677 |
GO:0045019 | negative regulation of nitric oxide biosynthetic process | 0.006299989005677 |
GO:0048554 | positive regulation of metalloenzyme activity | 0.006299989005677 |
GO:0008047 | enzyme activator activity | 0.00642131613139922 |
GO:0046426 | negative regulation of JAK-STAT cascade | 0.00704309866806752 |
GO:0001937 | negative regulation of endothelial cell proliferation | 0.00704309866806752 |
GO:0060056 | mammary gland involution | 0.00704309866806752 |
GO:0003779 | actin binding | 0.00704309866806752 |
GO:0043409 | negative regulation of MAPKKK cascade | 0.0104982558724032 |
GO:0009892 | negative regulation of metabolic process | 0.0108361950797176 |
GO:0001936 | regulation of endothelial cell proliferation | 0.0108361950797176 |
GO:0008092 | cytoskeletal protein binding | 0.0108361950797176 |
GO:0019217 | regulation of fatty acid metabolic process | 0.0115011763969493 |
GO:0030856 | regulation of epithelial cell differentiation | 0.0115011763969493 |
GO:0001935 | endothelial cell proliferation | 0.0116269258240364 |
GO:0016599 | caveolar membrane | 0.0116269258240364 |
GO:0019229 | regulation of vasoconstriction | 0.0116269258240364 |
GO:0005901 | caveola | 0.0117265153474903 |
GO:0045428 | regulation of nitric oxide biosynthetic process | 0.0117265153474903 |
GO:0000188 | inactivation of MAPK activity | 0.0117265153474903 |
GO:0019915 | sequestering of lipid | 0.0125944559437872 |
GO:0007010 | cytoskeleton organization and biogenesis | 0.0131029077561029 |
GO:0016504 | protease activator activity | 0.013737900740806 |
GO:0000299 | integral to membrane of membrane fraction | 0.013737900740806 |
GO:0016043 | cellular component organization and biogenesis | 0.013749311394344 |
GO:0046425 | regulation of JAK-STAT cascade | 0.0140315153656317 |
GO:0042311 | vasodilation | 0.0140692156112715 |
GO:0042310 | vasoconstriction | 0.0140692156112715 |
GO:0046209 | nitric oxide metabolic process | 0.0140692156112715 |
GO:0043407 | negative regulation of MAP kinase activity | 0.0140692156112715 |
GO:0042632 | cholesterol homeostasis | 0.0140692156112715 |
GO:0006809 | nitric oxide biosynthetic process | 0.0140692156112715 |
GO:0006940 | regulation of smooth muscle contraction | 0.0140692156112715 |
GO:0055088 | lipid homeostasis | 0.0140692156112715 |
GO:0051899 | membrane depolarization | 0.0140692156112715 |
GO:0055092 | sterol homeostasis | 0.0140692156112715 |
GO:0043408 | regulation of MAPKKK cascade | 0.0140692156112715 |
GO:0051016 | barbed-end actin filament capping | 0.0140692156112715 |
GO:0030835 | negative regulation of actin filament depolymerization | 0.0140692156112715 |
GO:0006641 | triacylglycerol metabolic process | 0.0140692156112715 |
GO:0051693 | actin filament capping | 0.0140692156112715 |
GO:0019216 | regulation of lipid metabolic process | 0.0140692156112715 |
GO:0065008 | regulation of biological quality | 0.0141602239531468 |
GO:0030834 | regulation of actin filament depolymerization | 0.0141602239531468 |
GO:0051260 | protein homooligomerization | 0.0141602239531468 |
GO:0030042 | actin filament depolymerization | 0.0141602239531468 |
GO:0001666 | response to hypoxia | 0.0141602239531468 |
GO:0030879 | mammary gland development | 0.0145734667951733 |
GO:0006639 | acylglycerol metabolic process | 0.0156225056388434 |
GO:0046486 | glycerolipid metabolic process | 0.0157301330214369 |
GO:0006638 | neutral lipid metabolic process | 0.0157301330214369 |
GO:0006939 | smooth muscle contraction | 0.0158307499795965 |
GO:0006662 | glycerol ether metabolic process | 0.0158307499795965 |
GO:0007259 | JAK-STAT cascade | 0.0159795788235808 |
GO:0051241 | negative regulation of multicellular organismal process | 0.0159795788235808 |
GO:0001570 | vasculogenesis | 0.0159795788235808 |
GO:0051259 | protein oligomerization | 0.0159795788235808 |
GO:0008064 | regulation of actin polymerization and/or depolymerization | 0.0159795788235808 |
GO:0009890 | negative regulation of biosynthetic process | 0.0159795788235808 |
GO:0051261 | protein depolymerization | 0.0159795788235808 |
GO:0032535 | regulation of cellular component size | 0.0159795788235808 |
GO:0032956 | regulation of actin cytoskeleton organization and biogenesis | 0.0159795788235808 |
GO:0030832 | regulation of actin filament length | 0.0159795788235808 |
GO:0006937 | regulation of muscle contraction | 0.0159795788235808 |
GO:0051129 | negative regulation of cellular component organization and biogenesis | 0.0159795788235808 |
GO:0045121 | lipid raft | 0.0159795788235808 |
GO:0003018 | vascular process in circulatory system | 0.0159795788235808 |
GO:0035150 | regulation of tube size | 0.0159795788235808 |
GO:0051493 | regulation of cytoskeleton organization and biogenesis | 0.0159795788235808 |
GO:0033043 | regulation of organelle organization and biogenesis | 0.0159795788235808 |
GO:0050880 | regulation of blood vessel size | 0.0159795788235808 |
GO:0048471 | perinuclear region of cytoplasm | 0.0159795788235808 |
GO:0048523 | negative regulation of cellular process | 0.0159795788235808 |
GO:0030855 | epithelial cell differentiation | 0.0159795788235808 |
GO:0006469 | negative regulation of protein kinase activity | 0.0159795788235808 |
GO:0033673 | negative regulation of kinase activity | 0.0159795788235808 |
GO:0051348 | negative regulation of transferase activity | 0.0166693735062763 |
GO:0008154 | actin polymerization and/or depolymerization | 0.0173431207786081 |
GO:0048519 | negative regulation of biological process | 0.0175818613596208 |
GO:0042391 | regulation of membrane potential | 0.0177991051732299 |
GO:0005938 | cell cortex | 0.0194749469217216 |
GO:0043086 | negative regulation of catalytic activity | 0.0194749469217216 |
GO:0051128 | regulation of cellular component organization and biogenesis | 0.0221237649373292 |
GO:0006874 | cellular calcium ion homeostasis | 0.0239057884286992 |
GO:0043405 | regulation of MAP kinase activity | 0.0240510247413231 |
GO:0055074 | calcium ion homeostasis | 0.0241931599858816 |
GO:0006996 | organelle organization and biogenesis | 0.0249903506627886 |
GO:0006875 | cellular metal ion homeostasis | 0.0256294601944308 |
GO:0055065 | metal ion homeostasis | 0.0258698153636066 |
GO:0051248 | negative regulation of protein metabolic process | 0.0258698153636066 |
GO:0048732 | gland development | 0.0278617492606456 |
GO:0044271 | nitrogen compound biosynthetic process | 0.0283283464028833 |
GO:0003012 | muscle system process | 0.030325157929097 |
GO:0006936 | muscle contraction | 0.030325157929097 |
GO:0045596 | negative regulation of cell differentiation | 0.0307538950754711 |
GO:0009968 | negative regulation of signal transduction | 0.0322439760883674 |
GO:0007519 | skeletal muscle development | 0.03277731045783 |
GO:0008015 | blood circulation | 0.03277731045783 |
GO:0003013 | circulatory system process | 0.03277731045783 |
GO:0030005 | cellular di-, tri-valent inorganic cation homeostasis | 0.03277731045783 |
GO:0055066 | di-, tri-valent inorganic cation homeostasis | 0.0334994817972183 |
GO:0006816 | calcium ion transport | 0.0345952572881161 |
GO:0030003 | cellular cation homeostasis | 0.0345952572881161 |
GO:0051093 | negative regulation of developmental process | 0.0345952572881161 |
GO:0055080 | cation homeostasis | 0.0352516481138001 |
GO:0005515 | protein binding | 0.0352516481138001 |
GO:0051336 | regulation of hydrolase activity | 0.0353110778694542 |
GO:0051240 | positive regulation of multicellular organismal process | 0.0375581357212475 |
GO:0008285 | negative regulation of cell proliferation | 0.0375581357212475 |
GO:0000165 | MAPKKK cascade | 0.0375581357212475 |
GO:0048771 | tissue remodeling | 0.0378576733827624 |
GO:0014706 | striated muscle development | 0.0378576733827624 |
GO:0002009 | morphogenesis of an epithelium | 0.0378576733827624 |
GO:0006461 | protein complex assembly | 0.0381562639468962 |
GO:0045859 | regulation of protein kinase activity | 0.0384499058216531 |
GO:0043549 | regulation of kinase activity | 0.0395773064087564 |
GO:0015674 | di-, tri-valent inorganic cation transport | 0.0395773064087564 |
GO:0043085 | positive regulation of catalytic activity | 0.0395773064087564 |
GO:0051338 | regulation of transferase activity | 0.0395773064087564 |
GO:0055082 | cellular chemical homeostasis | 0.0421181734176855 |
GO:0006873 | cellular ion homeostasis | 0.0421181734176855 |
GO:0035239 | tube morphogenesis | 0.0423645627375206 |
GO:0005096 | GTPase activator activity | 0.0428887853344136 |
GO:0045595 | regulation of cell differentiation | 0.0431253665652444 |
GO:0009889 | regulation of biosynthetic process | 0.0433582941140103 |
GO:0006631 | fatty acid metabolic process | 0.0444132124674194 |
GO:0007517 | muscle development | 0.0452719842466176 |
GO:0050801 | ion homeostasis | 0.0452719842466176 |
GO:0010324 | membrane invagination | 0.0452719842466176 |
GO:0006897 | endocytosis | 0.0452719842466176 |
GO:0048514 | blood vessel morphogenesis | 0.0462736517263243 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
epithelial bud | 3.29e-08 | 17 |
cardiovascular system | 1.53e-07 | 23 |
circulatory system | 1.53e-07 | 23 |
lung | 6.07e-07 | 14 |
respiratory tube | 6.07e-07 | 14 |
respiration organ | 6.07e-07 | 14 |
pair of lungs | 6.07e-07 | 14 |
lung primordium | 6.07e-07 | 14 |
lung bud | 6.07e-07 | 14 |
epithelial fold | 9.14e-07 | 20 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.829197 |
MA0004.1 | 0.303605 |
MA0006.1 | 0.16569 |
MA0007.1 | 0.790701 |
MA0009.1 | 0.709264 |
MA0014.1 | 0.0136923 |
MA0017.1 | 1.04297 |
MA0019.1 | 0.535691 |
MA0024.1 | 0.667197 |
MA0025.1 | 0.936082 |
MA0027.1 | 2.34178 |
MA0028.1 | 0.173587 |
MA0029.1 | 0.64639 |
MA0030.1 | 0.65267 |
MA0031.1 | 0.618697 |
MA0038.1 | 0.432665 |
MA0040.1 | 0.721328 |
MA0041.1 | 0.239557 |
MA0042.1 | 0.228771 |
MA0043.1 | 0.802848 |
MA0046.1 | 0.743934 |
MA0048.1 | 0.168666 |
MA0050.1 | 0.337476 |
MA0051.1 | 0.440863 |
MA0052.1 | 0.729105 |
MA0055.1 | 0.89968 |
MA0056.1 | 0 |
MA0057.1 | 0.151898 |
MA0058.1 | 0.223242 |
MA0059.1 | 0.658541 |
MA0060.1 | 0.108526 |
MA0061.1 | 0.805149 |
MA0063.1 | 0 |
MA0066.1 | 0.422624 |
MA0067.1 | 1.04514 |
MA0068.1 | 0.361347 |
MA0069.1 | 0.729433 |
MA0070.1 | 0.720077 |
MA0071.1 | 0.336739 |
MA0072.1 | 0.711905 |
MA0073.1 | 0.00478565 |
MA0074.1 | 0.390075 |
MA0076.1 | 0.200996 |
MA0077.1 | 0.691048 |
MA0078.1 | 0.471303 |
MA0081.1 | 0.252371 |
MA0083.1 | 0.802078 |
MA0084.1 | 1.3693 |
MA0087.1 | 0.760279 |
MA0088.1 | 0.0983922 |
MA0089.1 | 0 |
MA0090.1 | 0.753315 |
MA0091.1 | 0.315003 |
MA0092.1 | 0.753925 |
MA0093.1 | 0.179936 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.379666 |
MA0101.1 | 0.675688 |
MA0103.1 | 1.07649 |
MA0105.1 | 0.846872 |
MA0106.1 | 0.478503 |
MA0107.1 | 0.555009 |
MA0108.2 | 0.557195 |
MA0109.1 | 0 |
MA0111.1 | 0.78079 |
MA0113.1 | 0.452439 |
MA0114.1 | 0.797973 |
MA0115.1 | 0.805567 |
MA0116.1 | 1.52988 |
MA0117.1 | 0.774259 |
MA0119.1 | 1.25662 |
MA0122.1 | 0.793507 |
MA0124.1 | 0.992825 |
MA0125.1 | 0.920215 |
MA0130.1 | 0 |
MA0131.1 | 0.531427 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 0.838263 |
MA0136.1 | 0.408073 |
MA0139.1 | 4.16003 |
MA0140.1 | 0.379562 |
MA0141.1 | 0.210047 |
MA0142.1 | 0.604892 |
MA0143.1 | 0.467531 |
MA0144.1 | 0.129525 |
MA0145.1 | 0.0257706 |
MA0146.1 | 0.142424 |
MA0147.1 | 0.138228 |
MA0148.1 | 0.317692 |
MA0149.1 | 0.245177 |
MA0062.2 | 0.0662974 |
MA0035.2 | 0.383789 |
MA0039.2 | 0.382143 |
MA0138.2 | 0.523978 |
MA0002.2 | 0.0901987 |
MA0137.2 | 0.207733 |
MA0104.2 | 0.099275 |
MA0047.2 | 0.431964 |
MA0112.2 | 0.025769 |
MA0065.2 | 0.265926 |
MA0150.1 | 0.790482 |
MA0151.1 | 0 |
MA0152.1 | 0.432062 |
MA0153.1 | 0.854464 |
MA0154.1 | 1.03999 |
MA0155.1 | 1.71283 |
MA0156.1 | 0.200311 |
MA0157.1 | 0.574484 |
MA0158.1 | 0 |
MA0159.1 | 0.876351 |
MA0160.1 | 0.320315 |
MA0161.1 | 0 |
MA0162.1 | 0.0257461 |
MA0163.1 | 0.069011 |
MA0164.1 | 3.78388 |
MA0080.2 | 0.190316 |
MA0018.2 | 0.417217 |
MA0099.2 | 0.518072 |
MA0079.2 | 0.0563048 |
MA0102.2 | 1.42135 |
MA0258.1 | 0.376353 |
MA0259.1 | 0.408856 |
MA0442.1 | 0 |